<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font22 { font-size : 22; } .font23 { font-size : 23; } .font27 { font-size : 27; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font31 { font-size : 31; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font31">(.) </span>
   <span class="font27">drug </span>
   <span class="font23">HIV </span>
   <span class="font23">PDR </span>
   <span class="font22">resistance </span>
   <span class="font18">transmission </span>
   <span class="font17">prevalence </span>
   <span class="font17">antiretroviral </span>
   <span class="font16">(/) </span>
   <span class="font16">ART </span>
   <span class="font16">study </span>
   <span class="font15">(.–.) </span>
   <span class="font15">[]. </span>
   <span class="font15">patients </span>
   <span class="font15">{border-style </span>
   <span class="font14">China </span>
   <span class="font14">px;} </span>
   <span class="font14">#ffffff;} </span>
   <span class="font14">networks </span>
   <span class="font14">sequences </span>
   <span class="font14">.(/) </span>
   <span class="font14">[], </span>
   <span class="font14">individuals </span>
   <span class="font13">(.%) </span>
   <span class="font13">high </span>
   <span class="font13">Control </span>
   <span class="font13">mutations </span>
   <span class="font13">regions </span>
   <span class="font13">therapy </span>
   <span class="font13">associated </span>
   <span class="font13">initiating </span>
   <span class="font13">.collab: </span>
   <span class="font13">Center </span>
   <span class="font13">first-line </span>
   <span class="font13">included </span>
   <span class="font12">China. </span>
   <span class="font12">Disease </span>
   <span class="font12">Sichuan </span>
   <span class="font12">participants </span>
   <span class="font12">Antiretroviral </span>
   <span class="font12">Liangshan </span>
   <span class="font12">National </span>
   <span class="font12">surveillance </span>
   <span class="font12">(.%, </span>
   <span class="font12">Dehong </span>
   <span class="font12">Guangxi </span>
   <span class="font12">Pretreatment </span>
   <span class="font12">Title </span>
   <span class="font12">results </span>
   <span class="font12">subordinate </span>
   <span class="font12">treatment </span>
   <span class="font12">used </span>
   <span class="font12">CI: </span>
   <span class="font12">HIV- </span>
   <span class="font12">Liangshan, </span>
   <span class="font12">contained </span>
   <span class="font12">drugs </span>
   <span class="font12">genetic </span>
   <span class="font12">infected </span>
   <span class="font12">infection </span>
   <span class="font12">number </span>
   <span class="font12">prefecture </span>
   <span class="font12">px; </span>
   <span class="font12">region </span>
   <span class="font12">related </span>
   <span class="font12">{font-family </span>
   <span class="font11">Dis </span>
   <span class="font11">HIV-infected </span>
   <span class="font11">HIVDR </span>
   <span class="font11">IDUs </span>
   <span class="font11">NNRTI </span>
   <span class="font11">PDR. </span>
   <span class="font11">Prevention </span>
   <span class="font11">Prevention, </span>
   <span class="font11">Yunnan </span>
   <span class="font11">failure </span>
   <span class="font11">font-size </span>
   <span class="font11">mutation </span>
   <span class="font11">pretreatment </span>
   <span class="font11">reverse </span>
   <span class="font11">transcriptase </span>
   <span class="font11">(%) </span>
   <span class="font11">.%), </span>
   <span class="font11">China, </span>
   <span class="font11">Free </span>
   <span class="font11">However, </span>
   <span class="font11">Infect </span>
   <span class="font11">Lincang </span>
   <span class="font11">NRTI </span>
   <span class="font11">Prefecture </span>
   <span class="font11">Science </span>
   <span class="font11">adults </span>
   <span class="font11">al.Pretreatment </span>
   <span class="font11">analysis </span>
   <span class="font11">cell </span>
   <span class="font11">cohort </span>
   <span class="font11">counts </span>
   <span class="font11">data </span>
   <span class="font11">double; </span>
   <span class="font11">factors </span>
   <span class="font11">intercourse </span>
   <span class="font11">moderate </span>
   <span class="font11">network </span>
   <span class="font11">networks. </span>
   <span class="font11">obtained </span>
   <span class="font11">performed </span>
   <span class="font11">regimen </span>
   <span class="font11">regression </span>
   <span class="font11">subjects </span>
   <span class="font11">total, </span>
   <span class="font11">use </span>
   <span class="font11">virological </span>
   <span class="font11">AIDS/STD </span>
   <span class="font11">Chinese </span>
   <span class="font11">Commons </span>
   <span class="font11">Creative </span>
   <span class="font11">DRMs </span>
   <span class="font11">Protease </span>
   <span class="font11">Province, </span>
   <span class="font11">Shandong </span>
   <span class="font11">Table </span>
   <span class="font11">WHO </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">defined </span>
   <span class="font11">grid.. </span>
   <span class="font11">inhibitor </span>
   <span class="font11">initiated </span>
   <span class="font11">initiation </span>
   <span class="font11">logistic </span>
   <span class="font11">populations </span>
   <span class="font11">previous </span>
   <span class="font11">recruited </span>
   <span class="font11">reverse-transcriptase </span>
   <span class="font11">solid; </span>
   <span class="font11">transmitted </span>
   <span class="font11">virus </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11"> Others </span>
   <span class="font11">&amp;lt; . </span>
   <span class="font11">(/), </span>
   <span class="font11">(ART) </span>
   <span class="font11">.%) </span>
   <span class="font11">AIDS </span>
   <span class="font11">Antimicrob </span>
   <span class="font11">Chemother </span>
   <span class="font11">Dehong, </span>
   <span class="font11">Drug </span>
   <span class="font11">Funding </span>
   <span class="font11">HX, </span>
   <span class="font11">IV, </span>
   <span class="font11">LL, </span>
   <span class="font11">NFATP </span>
   <span class="font11">Non-nucleoside </span>
   <span class="font11">Number </span>
   <span class="font11">Province </span>
   <span class="font11">RK, </span>
   <span class="font11">Technology </span>
   <span class="font11">Total </span>
   <span class="font11">according </span>
   <span class="font11">areas </span>
   <span class="font11">bold </span>
   <span class="font11">common </span>
   <span class="font11">contributed </span>
   <span class="font11">courier; </span>
   <span class="font11">cross-sectional </span>
   <span class="font11">distance </span>
   <span class="font11">drug-resistant </span>
   <span class="font11">em; </span>
   <span class="font11">estimate </span>
   <span class="font11">followed </span>
   <span class="font11">immunodeficiency </span>
   <span class="font11">inhibitor, </span>
   <span class="font11">inhibitors </span>
   <span class="font11">mortality </span>
   <span class="font11">multivariate </span>
   <span class="font11">networks, </span>
   <span class="font11">odds </span>
   <span class="font11">overall </span>
   <span class="font11">people </span>
   <span class="font11">potential </span>
   <span class="font11">pt;} </span>
   <span class="font11">rates </span>
   <span class="font11">ratio </span>
   <span class="font11">receiving </span>
   <span class="font11">regions, </span>
   <span class="font11">resistance. </span>
   <span class="font11">sampling </span>
   <span class="font11">school </span>
   <span class="font11">study, </span>
   <span class="font11">threshold </span>
   <span class="font11">users </span>
   <span class="font11">using </span>
   <span class="font11"> CRF_BC </span>
   <span class="font11"> Unknown </span>
   <span class="font11">  &amp;lt;  </span>
   <span class="font11">  ≥  </span>
  </p>
 </body>
</html>
